Martin GamerAssociate Director, Early Stage Bioprocess Development at Boehringer Ingelheim Pharma GmbH & Co. KG
Martin is Associate Director within the Early Stage Bioprocess Development unit at Boehringer Ingelheim. He is leading cell line development programs and technology evaluations for CHO-based biologics manufacturing. Before joining Boehringer Ingelheim Martin was Team Leader for high throughput expression technologies at Protagen AG. Martin holds a PhD from the Technical University of Braunschweig on the establishment of novel expression hosts for applications in Industrial Biotechnology.